What triethylene glycol has to do with ashwagandha sleep effects
Ashwagandha (Withania somnifera) is best known for its withanolide content, but a 2017 study isolated triethylene glycol from the leaves and reported sleep-inducing activity in mice. This is the basis for the claim that a non-withanolide constituent may contribute to the herb's traditional reputation as a sleep aid. The finding is preliminary and animal-based, so it describes a candidate mechanism rather than an established human pathway.
Most human trials of ashwagandha use standardized root extracts rather than isolated triethylene glycol, so the molecule responsible for any sleep benefit in people has not been pinned down. The diagram traces a proposed route, not a proven one.
What human trials actually report
Several small randomized trials suggest standardized ashwagandha extract may modestly improve self-reported sleep quality and sleep onset latency, often alongside reductions in perceived stress and cortisol. Effects in these studies tend to be small to moderate, and trial quality varies. Ashwagandha is not a sedative and should not be treated as a substitute for evaluated treatment of insomnia or an anxiety disorder.
This is general educational information, not medical advice. Anyone considering ashwagandha, especially during pregnancy, with thyroid conditions, or alongside sedatives or immunosuppressants, should consult a qualified healthcare professional first.